Literature DB >> 7897401

The use of ion-sensitive electrodes and fluorescence imaging in hippocampal slices for studying pathological changes of intracellular Ca2+ regulation.

P Schubert1, F Keller, Y Nakamura, K Rudolphi.   

Abstract

The physiological regulation of the intracellular Ca2+ homeostasis and its pathological alteration has been studied in rat and gerbil hippocampal slices using ion-sensitive electrodes and the fluorescence imaging technique. The ischemia-induced intracellular Ca2+ rise, accentuated in the synaptic/dendritic layer of the vulnerable CA1 neurons was observed in vivo and could be replicated at an accelerated time course in the "ischemic" hippocampal slice superfused with unoxygenated, glucose-free medium. The intracellular Ca2+ loading, thought to be instrumental for the generation of postischemic nerve cell damage, seems to result from an increased Ca2+ release out of intracellular stores as well as from an enhanced synaptic Ca2+ influx. The latter is attributed to a depolarization-induced opening of the voltage-dependent Ca2+ channels and to an uncontrolled influx through "upregulated" NMDA receptor-operated channels. Such an ischemia-induced upregulation which is reported to occur physiologically by the activation of PKC, is reflected by the selective loss of the depressive control of the synaptic NMDA Ca2+ influx by adenosine. Ischemia also leads to a hypertrophy of astrocytes which may go along with an impairment of their physiological function to take up glutamate adding to the extracellular rise of the excitotoxic amino acids. A pathological activation of microglial cells and their transformation into macrophages, known to release oxygen radicals, may further add to neuronal damage. The observed neuroprotection by adenosine can be primarily ascribed to its limiting effect on a pathological membrane depolarization and its deleterious consequences. The more powerful neuroprotection by propentofylline, thought to act analogue to adenosine, seems to be achieved by additional mechanisms. This pharmacon depresses the ischemia-induced neuronal Ca2+ loading in vivo and in vitro, prevents the activation of astrocytes and interferes with the transformation as well as with the free radical formation of microglia-derived macrophages as demonstrated in complementary studies with fluorescence techniques on cell cultures.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7897401     DOI: 10.1007/978-3-7091-9350-1_6

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  4 in total

1.  Brain slices as models for neurodegenerative disease and screening platforms to identify novel therapeutics.

Authors:  Seongeun Cho; Andrew Wood; Mark R Bowlby
Journal:  Curr Neuropharmacol       Date:  2007-03       Impact factor: 7.363

2.  Selective regulation of NR2B by protein phosphatase-1 for the control of the NMDA receptor in neuroprotection.

Authors:  Mélissa Farinelli; Fabrice D Heitz; Benjamin F Grewe; Shiva K Tyagarajan; Fritjof Helmchen; Isabelle M Mansuy
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

Review 3.  Animal Toxins as Therapeutic Tools to Treat Neurodegenerative Diseases.

Authors:  Jessica M de Souza; Bruno D C Goncalves; Marcus V Gomez; Luciene B Vieira; Fabiola M Ribeiro
Journal:  Front Pharmacol       Date:  2018-02-23       Impact factor: 5.810

Review 4.  Astrocyte metabolism and signaling during brain ischemia.

Authors:  David J Rossi; James D Brady; Claudia Mohr
Journal:  Nat Neurosci       Date:  2007-11       Impact factor: 24.884

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.